業界のプレスリリース

Hovione and GEA announce a strategic collaboration to advance Continuous Tableting

14 Dec 2022

Photo 1: Navin Lakhanpaul, Global Head Pharma-Solid Dosage, GEA (right) and Jean-Luc Herbeaux, CEO of Hovione (left), signed the agreement for close cooperation between the two companies. (Photo: GEA)

Navin Lakhanpaul, Global Head Pharma-Solid Dosage, GEA (right) and Jean-Luc Herbeaux, CEO of Hovione (left), signed the agreement for close cooperation between the two companies. (Photo: GEA)

Photo 2: Continuous Tableting at Hovione´s recently opened Facility in Portugal. (Photo Hovione)

Continuous Tableting at Hovione´s recently opened Facility in Portugal. (Photo Hovione)

Contact

Dr. Michael Golek

GEA の概要

GEA は、世界レベルの食品製造プロセス技術を有するとともに、乳業、飲料、パーソナル・ホームケア、化学など食品以外の幅広い分野にも実績があり、2019年度の連結売上高は約49億ユーロとなりました。

Stay informed!

Are you a journalist? Then sign up to our press mailing list and select the topics you would like to be informed about

Media Relations

GEA Group Aktiengesellschaft
Ulmenstrasse 99
40476 Düsseldorf
Germany
pr@gea.com